| Jenburkt Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524731 |
NSE Symbol : - |
P/E(TTM) : 13.93 |
|
ISIN Demat : INE354A01013 |
Div & Yield% : 1.74 |
EPS(TTM) : 85.23 |
|
Book Value(₹) : 446.48 |
Market Cap(₹Cr) : 524.06 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 44.63 | 43.02 | 45.56 | 35.53 | 41.05 | 36.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.63 | 43.02 | 45.56 | 35.53 | 41.05 | 36.89 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.35 | 1.82 | 2.08 | 2.06 | 1.88 | 1.58 |
| Total Income | 48.98 | 44.84 | 47.64 | 37.58 | 42.93 | 38.47 |
| Total Expenditure | 34.33 | 35.59 | 32.45 | 26.57 | 30.19 | 28.07 |
| PBIDT | 14.65 | 9.24 | 15.18 | 11.01 | 12.74 | 10.40 |
| Interest | 0.13 | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 |
| PBDT | 14.52 | 9.13 | 15.08 | 10.90 | 12.63 | 10.29 |
| Depreciation | 0.81 | 0.83 | 0.74 | 0.72 | 0.79 | 0.78 |
| Tax | 3.64 | 3.00 | 4.00 | 2.00 | 3.58 | 3.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.78 | -0.63 | 0.17 | 0.39 | -0.28 | 0.01 |
| Reported Profit After Tax | 10.85 | 5.93 | 10.16 | 7.79 | 8.54 | 6.51 |
| Extra-ordinary Items | -2.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13.75 | 5.93 | 10.16 | 7.79 | 8.54 | 6.51 |
| EPS (Unit Curr.) | 24.58 | 13.44 | 23.03 | 17.66 | 19.34 | 14.75 |
| EPS (Adj) (Unit Curr.) | 24.58 | 13.44 | 23.03 | 17.66 | 19.34 | 14.75 |
| Calculated EPS (Unit Curr.) | 24.58 | 13.44 | 23.03 | 17.66 | 19.34 | 14.75 |
| Calculated EPS (Adj) (Unit Curr.) | 24.58 | 13.44 | 23.03 | 17.66 | 19.34 | 14.75 |
| Calculated EPS (Ann.) (Unit Curr.) | 98.33 | 53.76 | 92.12 | 70.62 | 77.37 | 58.98 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 98.33 | 53.76 | 92.12 | 70.62 | 77.37 | 58.98 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 32.83 | 21.48 | 33.32 | 30.99 | 31.04 | 28.19 |
| PBDTM(%) | 32.53 | 21.22 | 33.10 | 30.68 | 30.77 | 27.89 |
| PATM(%) | 24.31 | 13.78 | 22.30 | 21.93 | 20.80 | 17.65 |
